Report cover image

Global Natural APIs (Active Pharmaceutical Ingredients) Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 101 Pages
SKU # APRC20339896

Description

Summary

According to APO Research, The global Natural APIs (Active Pharmaceutical Ingredients) market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Natural APIs (Active Pharmaceutical Ingredients) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Natural APIs (Active Pharmaceutical Ingredients) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Natural APIs (Active Pharmaceutical Ingredients) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Natural APIs (Active Pharmaceutical Ingredients) include Sanofi SA, Novartis AG, Roquette Freres SA, Kothari Phytochemicals, GSK plc, Evonik Industries AG, Centroflora Group, Cargill and BASF SE, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Natural APIs (Active Pharmaceutical Ingredients), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural APIs (Active Pharmaceutical Ingredients).

The Natural APIs (Active Pharmaceutical Ingredients) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Natural APIs (Active Pharmaceutical Ingredients) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Natural APIs (Active Pharmaceutical Ingredients) Segment by Company

Sanofi SA
Novartis AG
Roquette Freres SA
Kothari Phytochemicals
GSK plc
Evonik Industries AG
Centroflora Group
Cargill
BASF SE
Arboris
Natural APIs (Active Pharmaceutical Ingredients) Segment by Type

Terpenoids
Alkaloids
Lignin
Flavonoids
Anthocyanin
Phenolic Acids
Others
Natural APIs (Active Pharmaceutical Ingredients) Segment by Application

Health Products
Biology
Pharmaceuticals
Others
Natural APIs (Active Pharmaceutical Ingredients) Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natural APIs (Active Pharmaceutical Ingredients) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Natural APIs (Active Pharmaceutical Ingredients) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natural APIs (Active Pharmaceutical Ingredients).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natural APIs (Active Pharmaceutical Ingredients) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Natural APIs (Active Pharmaceutical Ingredients) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

101 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales Estimates and Forecasts (2020-2031)
1.3 Natural APIs (Active Pharmaceutical Ingredients) Market by Type
1.3.1 Terpenoids
1.3.2 Alkaloids
1.3.3 Lignin
1.3.4 Flavonoids
1.3.5 Anthocyanin
1.3.6 Phenolic Acids
1.3.7 Others
1.4 Global Natural APIs (Active Pharmaceutical Ingredients) Market Size by Type
1.4.1 Global Natural APIs (Active Pharmaceutical Ingredients) Market Size Overview by Type (2020-2031)
1.4.2 Global Natural APIs (Active Pharmaceutical Ingredients) Historic Market Size Review by Type (2020-2025)
1.4.3 Global Natural APIs (Active Pharmaceutical Ingredients) Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Natural APIs (Active Pharmaceutical Ingredients) Sales Breakdown by Type (2020-2025)
1.5.2 Europe Natural APIs (Active Pharmaceutical Ingredients) Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales Breakdown by Type (2020-2025)
1.5.4 South America Natural APIs (Active Pharmaceutical Ingredients) Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Natural APIs (Active Pharmaceutical Ingredients) Industry Trends
2.2 Natural APIs (Active Pharmaceutical Ingredients) Industry Drivers
2.3 Natural APIs (Active Pharmaceutical Ingredients) Industry Opportunities and Challenges
2.4 Natural APIs (Active Pharmaceutical Ingredients) Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Natural APIs (Active Pharmaceutical Ingredients) Revenue (2020-2025)
3.2 Global Top Players by Natural APIs (Active Pharmaceutical Ingredients) Sales (2020-2025)
3.3 Global Top Players by Natural APIs (Active Pharmaceutical Ingredients) Price (2020-2025)
3.4 Global Natural APIs (Active Pharmaceutical Ingredients) Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Natural APIs (Active Pharmaceutical Ingredients) Major Company Production Sites & Headquarters
3.6 Global Natural APIs (Active Pharmaceutical Ingredients) Company, Product Type & Application
3.7 Global Natural APIs (Active Pharmaceutical Ingredients) Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Natural APIs (Active Pharmaceutical Ingredients) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Natural APIs (Active Pharmaceutical Ingredients) Players Market Share by Revenue in 2024
3.8.3 2023 Natural APIs (Active Pharmaceutical Ingredients) Tier 1, Tier 2, and Tier 3
4 Natural APIs (Active Pharmaceutical Ingredients) Regional Status and Outlook
4.1 Global Natural APIs (Active Pharmaceutical Ingredients) Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Natural APIs (Active Pharmaceutical Ingredients) Historic Market Size by Region
4.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales in Volume by Region (2020-2025)
4.2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales in Value by Region (2020-2025)
4.2.3 Global Natural APIs (Active Pharmaceutical Ingredients) Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Natural APIs (Active Pharmaceutical Ingredients) Forecasted Market Size by Region
4.3.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales in Volume by Region (2026-2031)
4.3.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales in Value by Region (2026-2031)
4.3.3 Global Natural APIs (Active Pharmaceutical Ingredients) Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Natural APIs (Active Pharmaceutical Ingredients) by Application
5.1 Natural APIs (Active Pharmaceutical Ingredients) Market by Application
5.1.1 Health Products
5.1.2 Biology
5.1.3 Pharmaceuticals
5.1.4 Others
5.2 Global Natural APIs (Active Pharmaceutical Ingredients) Market Size by Application
5.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Market Size Overview by Application (2020-2031)
5.2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Historic Market Size Review by Application (2020-2025)
5.2.3 Global Natural APIs (Active Pharmaceutical Ingredients) Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Natural APIs (Active Pharmaceutical Ingredients) Sales Breakdown by Application (2020-2025)
5.3.2 Europe Natural APIs (Active Pharmaceutical Ingredients) Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales Breakdown by Application (2020-2025)
5.3.4 South America Natural APIs (Active Pharmaceutical Ingredients) Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Sanofi SA
6.1.1 Sanofi SA Comapny Information
6.1.2 Sanofi SA Business Overview
6.1.3 Sanofi SA Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi SA Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.1.5 Sanofi SA Recent Developments
6.2 Novartis AG
6.2.1 Novartis AG Comapny Information
6.2.2 Novartis AG Business Overview
6.2.3 Novartis AG Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis AG Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.2.5 Novartis AG Recent Developments
6.3 Roquette Freres SA
6.3.1 Roquette Freres SA Comapny Information
6.3.2 Roquette Freres SA Business Overview
6.3.3 Roquette Freres SA Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roquette Freres SA Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.3.5 Roquette Freres SA Recent Developments
6.4 Kothari Phytochemicals
6.4.1 Kothari Phytochemicals Comapny Information
6.4.2 Kothari Phytochemicals Business Overview
6.4.3 Kothari Phytochemicals Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kothari Phytochemicals Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.4.5 Kothari Phytochemicals Recent Developments
6.5 GSK plc
6.5.1 GSK plc Comapny Information
6.5.2 GSK plc Business Overview
6.5.3 GSK plc Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GSK plc Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.5.5 GSK plc Recent Developments
6.6 Evonik Industries AG
6.6.1 Evonik Industries AG Comapny Information
6.6.2 Evonik Industries AG Business Overview
6.6.3 Evonik Industries AG Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Evonik Industries AG Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.6.5 Evonik Industries AG Recent Developments
6.7 Centroflora Group
6.7.1 Centroflora Group Comapny Information
6.7.2 Centroflora Group Business Overview
6.7.3 Centroflora Group Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Centroflora Group Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.7.5 Centroflora Group Recent Developments
6.8 Cargill
6.8.1 Cargill Comapny Information
6.8.2 Cargill Business Overview
6.8.3 Cargill Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cargill Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.8.5 Cargill Recent Developments
6.9 BASF SE
6.9.1 BASF SE Comapny Information
6.9.2 BASF SE Business Overview
6.9.3 BASF SE Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BASF SE Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.9.5 BASF SE Recent Developments
6.10 Arboris
6.10.1 Arboris Comapny Information
6.10.2 Arboris Business Overview
6.10.3 Arboris Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Arboris Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.10.5 Arboris Recent Developments
7 North America by Country
7.1 North America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country
7.1.1 North America Natural APIs (Active Pharmaceutical Ingredients) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2020-2025)
7.1.3 North America Natural APIs (Active Pharmaceutical Ingredients) Sales Forecast by Country (2026-2031)
7.2 North America Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country
7.2.1 North America Natural APIs (Active Pharmaceutical Ingredients) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country (2020-2025)
7.2.3 North America Natural APIs (Active Pharmaceutical Ingredients) Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Natural APIs (Active Pharmaceutical Ingredients) Sales by Country
8.1.1 Europe Natural APIs (Active Pharmaceutical Ingredients) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2020-2025)
8.1.3 Europe Natural APIs (Active Pharmaceutical Ingredients) Sales Forecast by Country (2026-2031)
8.2 Europe Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country
8.2.1 Europe Natural APIs (Active Pharmaceutical Ingredients) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country (2020-2025)
8.2.3 Europe Natural APIs (Active Pharmaceutical Ingredients) Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales by Country
9.1.1 Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2020-2025)
9.1.3 Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country
9.2.1 Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country
10.1.1 South America Natural APIs (Active Pharmaceutical Ingredients) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2020-2025)
10.1.3 South America Natural APIs (Active Pharmaceutical Ingredients) Sales Forecast by Country (2026-2031)
10.2 South America Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country
10.2.1 South America Natural APIs (Active Pharmaceutical Ingredients) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country (2020-2025)
10.2.3 South America Natural APIs (Active Pharmaceutical Ingredients) Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales by Country
11.1.1 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2020-2025)
11.1.3 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country
11.2.1 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Natural APIs (Active Pharmaceutical Ingredients) Value Chain Analysis
12.1.1 Natural APIs (Active Pharmaceutical Ingredients) Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Natural APIs (Active Pharmaceutical Ingredients) Production Mode & Process
12.2 Natural APIs (Active Pharmaceutical Ingredients) Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Natural APIs (Active Pharmaceutical Ingredients) Distributors
12.2.3 Natural APIs (Active Pharmaceutical Ingredients) Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.